407 related articles for article (PubMed ID: 2468514)
1. Tissue levels and in vivo release of tachykinins and GABA in striatum and substantia nigra of rat brain after unilateral striatal dopamine denervation.
Lindefors N; Brodin E; Tossman U; Segovia J; Ungerstedt U
Exp Brain Res; 1989; 74(3):527-34. PubMed ID: 2468514
[TBL] [Abstract][Full Text] [Related]
2. Effects of GABA and L-glutamic acid on the potassium-evoked in vitro release of substance P- and neurokinin A-like immunoreactivities are different in the rat striatum and substantia nigra.
Humpel C; Saria A
Neurosci Lett; 1989 Oct; 105(1-2):159-63. PubMed ID: 2484728
[TBL] [Abstract][Full Text] [Related]
3. Interactions of dopaminergic and GABAergic neurotransmission: impact of 6-hydroxydopamine lesions into the substantia nigra of rats.
Hossain MA; Weiner N
J Pharmacol Exp Ther; 1995 Oct; 275(1):237-44. PubMed ID: 7562556
[TBL] [Abstract][Full Text] [Related]
4. Regulation of neurotensin-containing neurons in the rat striatum and substantia nigra. Effects of unilateral nigral lesion with 6-hydroxydopamine on neurotensin content and its binding site density.
Masuo Y; Pélaprat D; Montagne MN; Scherman D; Rostène W
Brain Res; 1990 Mar; 510(2):203-10. PubMed ID: 1970504
[TBL] [Abstract][Full Text] [Related]
5. Striatonigral GABA, dynorphin, substance P and neurokinin A modulation of nigrostriatal dopamine release: evidence for direct regulatory mechanisms.
Reid MS; Herrera-Marschitz M; Hökfelt T; Lindefors N; Persson H; Ungerstedt U
Exp Brain Res; 1990; 82(2):293-303. PubMed ID: 1704847
[TBL] [Abstract][Full Text] [Related]
6. Unilateral 6-hydroxydopamine lesion of dopamine neurons and subchronic L-DOPA administration in the adult rat alters the expression of the vesicular GABA transporter in different subsets of striatal neurons and in the substantia nigra, pars reticulata.
Wang H; Katz J; Dagostino P; Soghomonian JJ
Neuroscience; 2007 Mar; 145(2):727-37. PubMed ID: 17218060
[TBL] [Abstract][Full Text] [Related]
7. Subchronic haloperidol treatment decreases the in vivo release of tachykinins in rat substantia nigra.
Lindefors N; Brodin E; Ungerstedt U
Eur J Pharmacol; 1989 Feb; 161(1):95-8. PubMed ID: 2470596
[TBL] [Abstract][Full Text] [Related]
8. Muscarinic antagonists in substantia nigra influence the decarboxylation of L-dopa in striatum.
Izurieta-Sánchez P; Sarre S; Ebinger G; Michotte Y
Eur J Pharmacol; 2000 Jul; 399(2-3):151-60. PubMed ID: 10884514
[TBL] [Abstract][Full Text] [Related]
9. Nigrostriatal dopamine neurons are required to maintain basal levels of substance P in the rat substantia nigra.
Cruz CJ; Beckstead RM
Neuroscience; 1989; 30(2):331-8. PubMed ID: 2473415
[TBL] [Abstract][Full Text] [Related]
10. Modulation of methylenedioxymethamphetamine-induced striatal dopamine release by the interaction between serotonin and gamma-aminobutyric acid in the substantia nigra.
Yamamoto BK; Nash JF; Gudelsky GA
J Pharmacol Exp Ther; 1995 Jun; 273(3):1063-70. PubMed ID: 7791076
[TBL] [Abstract][Full Text] [Related]
11. D1 dopamine receptor-mediated substance P depletion in the striatonigral neurons of rats subjected to neonatal dopaminergic denervation: implications for self-injurious behavior.
Sivam SP
Brain Res; 1989 Oct; 500(1-2):119-30. PubMed ID: 2481560
[TBL] [Abstract][Full Text] [Related]
12. In vivo detection of immunoreactive neurokinin A release within rat substantia nigra and its dependency on a dopaminergic input.
Furmidge LJ; Duggan AW; Arbuthnott GW
Brain Res; 1995 May; 679(2):241-8. PubMed ID: 7633884
[TBL] [Abstract][Full Text] [Related]
13. Striatal dopamine and glutamate release: effects of intranigral injections of substance P.
Reid MS; Herrera-Marschitz M; Kehr J; Ungerstedt U
Acta Physiol Scand; 1990 Dec; 140(4):527-37. PubMed ID: 1707211
[TBL] [Abstract][Full Text] [Related]
14. The striatonigral dynorphin pathway of the rat studied with in vivo microdialysis--II. Effects of dopamine D1 and D2 receptor agonists.
You ZB; Herrera-Marschitz M; Nylander I; Goiny M; O'Connor WT; Ungerstedt U; Terenius L
Neuroscience; 1994 Nov; 63(2):427-34. PubMed ID: 7891856
[TBL] [Abstract][Full Text] [Related]
15. Effect of ischemia on the in vivo release of striatal dopamine, glutamate, and gamma-aminobutyric acid studied by intracerebral microdialysis.
Globus MY; Busto R; Dietrich WD; Martinez E; Valdes I; Ginsberg MD
J Neurochem; 1988 Nov; 51(5):1455-64. PubMed ID: 2902196
[TBL] [Abstract][Full Text] [Related]
16. Substance P and neurokinin A regulate by different mechanisms dopamine release from dendrites and nerve terminals of the nigrostriatal dopaminergic neurons.
Baruch P; Artaud F; Godeheu G; Barbeito L; Glowinski J; Chéramy A
Neuroscience; 1988 Jun; 25(3):889-98. PubMed ID: 2457187
[TBL] [Abstract][Full Text] [Related]
17. Differential regulation of glutamate, aspartate and gamma-amino-butyrate release by N-methyl-D-aspartate receptors in rat striatum after partial and extensive lesions to the nigro-striatal dopamine pathway.
Abarca J; Bustos G
Neurochem Int; 1999 Jul; 35(1):19-33. PubMed ID: 10403427
[TBL] [Abstract][Full Text] [Related]
18. gamma-Aminobutyric acid release in the globus pallidus in vivo after a 6-hydroxydopamine lesion in the substantia nigra of the rat.
Segovia J; Tossman U; Herrera-Marschitz M; Garcia-Munoz M; Ungerstedt U
Neurosci Lett; 1986 Oct; 70(3):364-8. PubMed ID: 3022198
[TBL] [Abstract][Full Text] [Related]
19. Evidence that [3H]dopamine is taken up and released from nondopaminergic nerve terminals in the rat substantia nigra in vitro.
Kelly E; Jenner P; Marsden CD
J Neurochem; 1985 Jul; 45(1):137-44. PubMed ID: 3923157
[TBL] [Abstract][Full Text] [Related]
20. Axonal transport of proteins and glycoproteins in the rat nigro-striatal pathway and the effects of 6-hydroxydopamine.
Roger LJ; Breese GR; Morell P
Brain Res; 1980 Sep; 197(1):95-112. PubMed ID: 6156743
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
